Immunotherapy (neoadjuvant)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immunotherapy (neoadjuvant), covering 2025-06-13 to 2025-06-13. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]